Chimeric Antigen Receptor (CAR) and T Cell Receptor (TCR) therapies are a game changer within cancer therapies and there is a place in history and huge recognition to both Novartis and Kite Pharma (now Gilead Sciences) for being the first companies to bring these novel therapies to market with Kymriah (tisagenlecleucel-t) and Yescarta (axicabtagene ciloleucel) respectively.
CAR/TCR Therapies in Oncology: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who needs to be on top of this hot and fast moving area of immune-oncology. This unique product is truly the only tool of its kind and is designed to give you a competitive edge in your CAR/TCR drug surveillance and intelligence, allowing you to power your decision making and advance your own interests.
Keeping you “In the know” Simply put, our mission is to fuel your knowledge of immune-oncology, to make you the first to know about very early technologies and startups, emerging clinical trial results, drug approvals and the ever-changing competitive landscape. CAR/TCR Therapies in Oncology: Analytical Tool achieves this by continuously scanning development in CAR/TCR and reporting: * Deals & Collaborations * New technologies/drugs (emerging from patents, grants, abstracts (see Conference Coverage) etc.) * Funding/Grants/IPOs * Filings & Approvals * Latest Clinical Trial Development & Results * Newly launched clinical trials * Conference Coverage of the world’s twelve leading meetings in oncology* * Quarterly & Annual Reporting
This puts you in control of most, if not all, day-to-day developments in your field while also benefiting from one of the most comprehensive commercial pipeline review & competitive assessment tools available on the market today! Identify, prioritize, and lead scientific assessment of oncology opportunities and competition by multiple factors such as: * Emerging Technologies * Target Novelty * Recent Funding * Early & Late Stage Pipeline * Biomarker/Companion Diagnostic Development (featured below) * Entered Deals & Alliances * Conference surveillance of world leading cancer meetings (featured below) * Combination Therapy Choices (featured below) * Outcome of Clinical Trials * Indication Selection & Expansion Choices * Drug Repositioning Opportunities
For 20 years we have supported better decision making across the oncology drug development industry. Your CAR/TCR Therapies in Oncology: Analytical Tool is based on two decades of proven methodology and transforms your computer’s desktop into a high capacity workbench within your area of choice. Even before launching this tool you have already eliminated the hundreds of hours of work needed to discover, process and piece together the thousands of sources that our team of oncology dedicated and highly experienced contents specialists have done on your behalf.
Your CAR/TCR Therapies in Oncology: Analytical Tool covers more than 173 companies plus partners who are today developing 520 CAR/TCR drugs where of 499 are in active development in cancer across 120 different targets. Any data and/or analysis from the Analytical Tool is yours to keep and data/graphs/tables can be easily exported into Excel/PDF and various graphic formats for mixing with your own proprietary information.
Let our expertise work for you With a simple point and click interface you can navigate the environment of current development, drill down into specific areas such as ongoing combination trials, biomarker analysis, selected scientific abstracts etc. and generate drug profiles, drug target profiles and company profiles (including Business Development & Licensing contacts). Any analysis generated by you is packed with presentation-ready graphs and tables to use in your reports and presentations.
Your key to access development at the world-leading cancer meetings The CAR/TCR Therapies in Oncology: Analytical Tool is continuously updated according to twelve of the world’s most influential meetings in oncology (AACR, ASCO, ASGCT, ASH, CMIT, EHA, EORTC-NCI-AACR, ESMO, SITC and BIO (International, Europe and Asia). If you are not able to attend any of the conference(s) in person, this Analytical Tool ensures that you are not missing out on the important take home messages you need to know about.
Run combination therapy analysis like no other The CAR/TCR Therapies in Oncology: Analytical Tool delivers comprehensive combination therapy analysis, allowing you to analyze combination therapies from multiple perspectives; from a single drug to virtually any cross section of oncology drugs of interest.
Unparalleled biomarker surveillance We also provide an outstanding oncology clinical biomarker surveillance & analysis, highlighting clinical phenotyping and patient stratification in trials. This analysis is based on our monitoring of the presence and usage of more than 1,000 biomarkers across tens of thousands of cancer clinical trials.
Support and inspiration at your finger-tips You also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.
A tool to grow with and keep you informed Unlike a static report which just represents a particular snapshot in time, all of the Analytical Tools come with one year of online access to twice-weekly updates in both contents and features, pipeline alerts and online support etc. You can choose to renew your access to these updates and support on a yearly basis or go over to our industry leading full service platform covering all oncology drug development, 1stOncology.
System Requirements - Browser Application (Supports: Internet Explorer, FireFox, Chrome and Safari)) - Internet access
Our reports have been used by over 10K customers, including:
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Regulatory/Medical Affairs), And Segment Forecasts, 2021 - 2028 Healthcare CRO Market Growth & Trends The global healthcare...
Biopreservation refers to the process of preserving cells, tissues or organs outside of their native environment for extended period of time. It has emerged as an effective preservation technique for long-term storage. Owing to this, biopreservation has become vital for the success of various clinical and commercial...
192 pages •
By Global Industry Analysts
• Apr 2021
- Global DNA Sequencing Market to Reach $28.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for DNA Sequencing estimated at US$9.4 Billion in the year 2020, is projected to reach a revised size of US$28.8 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. Diagnostics,...
Report Scope: This new report, Biomarkers: Technologies and Global Markets, provides a comprehensive analysis of the biomarkers market in a global context, including market forecasts and sales through 2025. The report analyzes the market, segmenting it into various product offerings (i.e., instruments, consumables [reagents,...
Beta Nerve Growth Factor (Beta NGF or NGF) - Drugs in Development, 2021 Summary Beta Nerve Growth Factor (Beta NGF or NGF) pipeline Target constitutes close to 11 molecules. The latest report Beta Nerve Growth Factor - Drugs in Development, 2021, outlays comprehensive information on the Beta Nerve...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
Androgenic Alopecia (Dermatology) - Drugs in Development, 2021 Summary Androgenic Alopecia (Dermatology) - Drugs in Development, 2021 provides an overview of the Androgenic Alopecia pipeline landscape. The report provides comprehensive information on the therapeutics under development for...
Bone Degeneration (Musculoskeletal) - Drugs in Development, 2021 Summary Bone Degeneration (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Bone Degeneration pipeline landscape. The report provides comprehensive information on the therapeutics under development for...
Chronic Inflammation (Immunology) - Drugs in Development, 2021 Summary Chronic Inflammation (Immunology) - Drugs in Development, 2021 provides an overview of the Chronic Inflammation pipeline landscape. The report provides comprehensive information on the therapeutics under development for...
Emesis (Vomiting) (Gastrointestinal) - Drugs in Development, 2021 Summary Emesis (Vomiting) (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Emesis (Vomiting) pipeline landscape. The report provides comprehensive information on the therapeutics under development...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.